A phase 1 study of concomitant high-dose lenalidomide and 5-azacitidine induction in the treatment of AML. [electronic resource]
Producer: 20130430Description: 725-8 p. digitalISSN:- 1476-5551
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Azacitidine -- administration & dosage
- Dose-Response Relationship, Drug
- Female
- Humans
- Lenalidomide
- Leukemia, Myeloid, Acute -- drug therapy
- Male
- Maximum Tolerated Dose
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Prognosis
- Prospective Studies
- Remission Induction
- Thalidomide -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Letter
There are no comments on this title.
Log in to your account to post a comment.